微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[284] 发布: 2013/05/03 15:42:45
Family Practice News Digital Network In one recent prospective, blinded study, 420 healthy, statin-naïve participants were randomized to 80 mg of atorvastatin or placebo for 6 months. Significantly more statin users (19) developed myalgia than did those on placebo (10). Creatine kinase ...
已读[101] 发布: 2013/05/02 16:31:09
已读[151] 发布: 2013/05/02 16:30:58
The Pharma Letter Sales of Zetia (ezetimibe) and Vytorin (ezetimibe/ simvastatin ), medicines for lowering LDL cholesterol, declined 3% to $1.0 billion, driven by lower sales of Vytorin, partially offset by growth of Zetia in the USA. Combined sales of Remicade (+6%) and ... and more »
已读[145] 发布: 2013/05/02 16:30:58
MarketWatch Sales of ZETIA (ezetimibe) and VYTORIN (ezetimibe/ simvastatin ), medicines for lowering LDL cholesterol, declined 3 percent to $1.0 billion in the first quarter driven by lower sales of VYTORIN, partially offset by growth of ZETIA in the United States ...
已读[92] 发布: 2013/05/02 16:30:57
PharmaTimes The cholesterol drugs Vytorin (ezetimibe plus simvastatin ) and Zetia (ezetimibe) reached $394 million and $629 million, down 11% and up 2% respectively. The anti-inflammatory Remicade (infliximab), the Johnson & Johnson drug which Merck sells outside ...
已读[293] 发布: 2013/05/02 16:28:17
Insider Monkey (blog) Interestingly, the companies also used a similar naming situation (ending the drugs in -or) for many of the brand names as well: Pfizer Inc. (NYSE:PFE)'s Lipitor ( atorvastatin ), Merck & Co., Inc. (NYSE:MRK)'s Zocor (simvastatin), and AstraZeneca plc ...
« 上一页  |   查看结果301-306共306   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘